Detection of Flunitrazepam and 7-Aminoflunitrazepam in Oral Fluid after Controlled Administration of Rohypnol®
The DOI matches its Crossref record.
Abstract
Although administered as a short-acting hypnotic for sleeping disorders, flunitrazepam, often in combination with alcohol or other drugs, was one of the most frequently abused benzodiazepines over the last 10 years. It has been reported in cases of driving under the influence, and its use is associated with marked psychomotor impairment. Studies over the last five years have investigated the use of oral fluid as an alternative matrix to blood and urine, especially when non-intrusive and quick sampling procedures are important (e.g., screening for drugs of abuse at the roadside and screening and confirmatory workplace drug testing). In this study, Rohypnol (flunitrazepam) was administered to four healthy volunteers, and oral fluid samples were collected by spitting into a polypropylene tube at fixed times between 0 and 6 h after the intake of a tablet of 1 mg. A specific and very sensitive method was developed, both for flunitrazepam and for its main metabolite 7-aminoflunitrazepam, based on solid-phase extraction of the oral fluid samples, stored at +4 degrees C, and gas chromatographic-mass spectrometric analyses using negative chemical ionization with methane as the ionization gas. The heptadeuterated parent compound and metabolite were used as internal standards. The respective limits of detection and quantitation were 0.05 microg/L and 0.1 microg/L for flunitrazepam, and 0.1 and 0.15 microg/L for 7-aminoflunitrazepam. The parent drug could only be detected when the analyses were performed within 12-24 h after collection of the oral fluid samples or when 2% of NaF was added to the collection tubes. The stability of flunitrazepam in oral fluid was poor, even at +4 degrees C, when no NaF was added to the sample. In any case, concentrations remained below 1 microg/L. The metabolite was detected in slightly higher concentrations, with or without the presence of NaF, reaching a maximum of 1-3 microg/L within 2-4 h after administration. In all cases the drug was detectable, but at extremely low concentrations, for 6 h after intake of a normal dose of Rohypnol and it will be an analytical challenge to come up with a sufficiently sensitive onsite test for low-dose benzodiazepines in oral fluid.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
Review: The physiology of saliva and transfer of drugs into saliva
Aps, J. K. M., & Martens, L. C. (2005) · Forensic Science International · doi:10.1016/j.forsciint.2004.10.026 · Cited by 560
Detection times of drugs of abuse in blood, urine, and oral fluid
Verstraete, A. G. (2004) · Therapeutic Drug Monitoring · doi:10.1097/00007691-200404000-00020 · Cited by 521
Self-citationOral fluid testing for drugs of abuse
Bosker, W. M., & Huestis, M. A. (2009) · Clinical Chemistry · doi:10.1373/clinchem.2008.108670 · Cited by 378
(2006) · PubMed Central · Cited by 241
Oral fluid drug testing: analytical approaches, issues and interpretation of results
Desrosiers, N. A., & Huestis, M. A. (2019) · Journal of Analytical Toxicology · doi:10.1093/jat/bkz048 · Cited by 123
Metadata
- Authors
- Samyn, N., De Boeck, G., Cirimele, V., Verstraete, A., & Kintz, P.
- Venue
- Journal of Analytical Toxicology
- Publisher
- Oxford University Press (OUP)
- Published
- 2002-05-01
- Volume
- 26
- Issue
- 4
- Pages
- 211-215
- ISSN
- 0146-4760 (ISSN-L)
- 1945-2403
- OpenAlex
- W2114371493
- Cited by
- 62
- References
- 0
- FWCI
- 4.34
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Detection of Flunitrazepam and 7-Aminoflunitrazepam in Oral Fluid after Controlled Administration of Rohypnol®. https://app.cochat.ai/papers/10.1093/jat/26.4.211
- The paper
- Samyn, N., De Boeck, G., Cirimele, V., Verstraete, A., & Kintz, P. (2002). Detection of Flunitrazepam and 7-Aminoflunitrazepam in Oral Fluid after Controlled Administration of Rohypnol®. Journal of Analytical Toxicology. https://doi.org/10.1093/jat/26.4.211
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.